A C/EBP-binding site in the transferrin promoter is essential for expression in the liver but not the brain of transgenic mice.

AUTOR(ES)

Theisen, M

RESUMO

The gene for the iron-binding protein transferrin is transcribed at a high level in liver hepatocytes but is also active in several other cell types, including oligodendrocytes in the brain. Enhancer elements between bp -560 and -44 of the transferrin gene promoter specifically activated transcription from a heterologous promoter in transgenic mouse liver and brain. Within this region, a potent cis-acting element between bp -98 and -83 was found to be essential for gene activity in both cultured hepatocytes and transgenic mouse liver. The -98 to -83 element contains a CCAAT sequence and is specifically bound by a nuclear factor from mouse liver that is homologous to rat liver C/EBP (CAAT enhancer-binding protein). Point mutations within this binding site inhibit factor binding and abolish transcription in transfected hepatoma cells. When placed in the context of the 3,000-bp transferrin promoter, the C/EBP binding site mutation causes a complete loss of transcription in transgenic mouse liver; however, transgene expression in the brain of the same animals was unaffected. These results suggest a modular structure for the transferrin promoter and demonstrate that deletions or specific point mutations can be used to generate transgene promoters with an activity more restricted than that of their endogenous counterparts.

Documentos Relacionados

• The C/EBP-binding region and adjacent sites regulate expression of the adipose P2 gene in human preadipocytes.
• Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene.
• Expression from the transferrin gene promoter in transgenic mice.
• Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization.
• A salivary amylase transgene is efficiently expressed in liver but not in parotid gland of transgenic mice.